These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 7698086)

  • 1. Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility.
    Daly AK; Cholerton S; Armstrong M; Idle JR
    Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):55-61. PubMed ID: 7698086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
    Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
    Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
    Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility--a review.
    Raunio H; Husgafvel-Pursiainen K; Anttila S; Hietanen E; Hirvonen A; Pelkonen O
    Gene; 1995 Jun; 159(1):113-21. PubMed ID: 7607565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity.
    Wormhoudt LW; Commandeur JN; Vermeulen NP
    Crit Rev Toxicol; 1999 Jan; 29(1):59-124. PubMed ID: 10066160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetic profile of xenobiotic enzyme metabolism in survivors of the Spanish toxic oil syndrome.
    Ladona MG; Izquierdo-Martinez M; Posada de la Paz MP; de la Torre R; Ampurdanés C; Segura J; Sanz EJ
    Environ Health Perspect; 2001 Apr; 109(4):369-75. PubMed ID: 11335185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic polymorphisms in xenobiotic metabolizing enzymes as a determinant of susceptibility to environmental mutagens and carcinogens in humans].
    Ozawa S
    Yakugaku Zasshi; 1997 Nov; 117(10-11):895-909. PubMed ID: 9414599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous genotyping of nine polymorphisms in xenobiotic-metabolizing enzymes by multiplex PCR amplification and single base extension.
    Knaapen AM; Ketelslegers HB; Gottschalk RW; Janssen RG; Paulussen AD; Smeets HJ; Godschalk RW; Van Schooten FJ; Kleinjans JC; Van Delft JH
    Clin Chem; 2004 Sep; 50(9):1664-8. PubMed ID: 15331501
    [No Abstract]   [Full Text] [Related]  

  • 10. Polymorphic enzymes of xenobiotic metabolism as modulators of acquired P53 mutations in bladder cancer.
    Brockmöller J; Kaiser R; Kerb R; Cascorbi I; Jaeger V; Roots I
    Pharmacogenetics; 1996 Dec; 6(6):535-45. PubMed ID: 9014203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.
    Nebert DW; McKinnon RA; Puga A
    DNA Cell Biol; 1996 Apr; 15(4):273-80. PubMed ID: 8639263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant genes of cytochrome P-450IID6, glutathione S-transferase class Mu, and arylamine N-acetyltransferase in lung cancer patients.
    Roots I; Brockmöller J; Drakoulis N; Loddenkemper R
    Clin Investig; 1992; 70(3-4):307-19. PubMed ID: 1355678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xenobiotic-metabolizing enzymes and cancer risk: correspondence between genotype and phenotype.
    Pelkonen O; Raunio H; Rautio A; Lang M
    IARC Sci Publ; 1999; (148):77-88. PubMed ID: 10493250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of mutant CYP1A1, NAT2 and GSTM1 alleles in normal Indians and Malays.
    Zhao B; Lee EJ; Wong JY; Yeoh PN; Gong NH
    Pharmacogenetics; 1995 Oct; 5(5):275-80. PubMed ID: 8563767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
    Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
    Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of drug-metabolizing enzymes in relation to individual susceptibility to industrial chemicals.
    Nakajima T; Aoyama T
    Ind Health; 2000 Apr; 38(2):143-52. PubMed ID: 10812837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of the polymorphic alleles of genes encoding phase 1 and phase 2 detoxication enzymes in patients with endometriosis].
    Ivashchenko TE; Shved NIu; Kramareva NA; Aĭlamazian EK; Baranov VS
    Genetika; 2003 Apr; 39(4):525-9. PubMed ID: 12760253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk.
    Brockmöller J; Cascorbi I; Kerb R; Roots I
    Cancer Res; 1996 Sep; 56(17):3915-25. PubMed ID: 8752158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of colorectal cancer.
    Kiyohara C
    J Epidemiol; 2000 Sep; 10(5):349-60. PubMed ID: 11059519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.
    Suzuki S; Muroishi Y; Nakanishi I; Oda Y
    J Gastroenterol; 2004; 39(3):220-30. PubMed ID: 15064998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.